MANNKIND CORP Fair Value Adjustment of Warrants
MANNKIND CORP (MNKD) reported Fair Value Adjustment of Warrants of -$5.49 million for the 12-month period ending 2017-12-31, per its 10-K filed 2019-02-26.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2019-02-26
- MANNKIND CORP fair value adjustment of warrants for the quarter ending 2016-12-31 was $2.51M.
- MANNKIND CORP fair value adjustment of warrants for the quarter ending 2016-09-30 was -$13.19M.
- MANNKIND CORP fair value adjustment of warrants for fiscal 2017 was -$5.49M.
- MANNKIND CORP fair value adjustment of warrants for fiscal 2016 was -$5.37M.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$5.49M 10-K · filed 2019-02-26 | |||
| 2016-12-31 | $2.51M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$10.68M derived: sum of 2 quarters · filed 2019-02-26 | -$5.37M 10-K · filed 2019-02-26 | |
| 2016-09-30 | -$13.19M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-11-09 | -$7.88M 10-Q · filed 2016-11-09 | ||
| 2016-06-30 | $5.31M 10-Q/A · filed 2016-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |